Clinical Trials
4 trialsNCT02685826 2023-10-06
A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma
Celgene
Phase 1/2 Completed
NCT02807454 2023-02-21
FUSIONMM-003
Celgene
Phase 2 Terminated
NCT02716805 2022-10-12
Phase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell Transplant
Ludwig Institute for Cancer Research
Phase 1 Terminated
NCT03000452 2018-10-16
FUSION-MM-005
Celgene
Phase 2 Completed